Genotypic characterization and in vitro activities of tigecycline and polymyxin B for members of the Enterobacteriaceae with decreased susceptibility to carbapenems

Journal of Medical Microbiology

Volumn 60, Issue 12, 2011, Pages 1813-1819

  Zhang, Rong ^a,b   Cai, Jia Chang ^a   Zhou, Hong Wei ^a   Nasu, Masao ^b   Chen, Gong Xiang ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM DERIVATIVE; ERTAPENEM; IMIPENEM; MEROPENEM; POLYMYXIN B; TIGECYCLINE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHINA; CITROBACTER FREUNDII; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENOTYPE; IN VITRO STUDY; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SERRATIA MARCESCENS;

ANTI-BACTERIAL AGENTS; BASE SEQUENCE; BETA-LACTAMASES; CARBAPENEMS; CONJUGATION, GENETIC; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; POLYMYXIN B; SEQUENCE ANALYSIS, DNA;

EID: 81355163734     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.025668-0     Document Type: Article

References (29)

1. Cai, J. C., Zhou, H. W., Zhang, R. & Chen, G. X. (2008a). Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing betalactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother 52, 2014-2018.
2. Cai, J. C., Zhou, H. W., Chen, G. X. & Zhang, R. (2008b). [Detection of plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in a strain of carbapenem-resistant Enterobacter cloacae]. Zhonghua Yi Xue Za Zhi 88, 135-138. (In Chinese).
3. Castanheira, M., Sader, H. S., Deshpande, L. M., Fritsche, T. R. & Jones, R. N. (2008). Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemaseand metallo-β-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother 52, 570-573.
4. Chen, L. R., Zhou, H. W., Cai, J. C., Zhang, R. & Chen, G. X. (2009a). Combination of IMP-4 metallo-beta-lactamase production and porin deficiency causes carbapenem resistance in a Klebsiella oxytoca clinical isolate. Diagn Microbiol Infect Dis 65, 163-167.
5. Chen, L. R., Zhou, H. W., Cai, J. C., Zhang, R. & Chen, G. X. (2009b). Detection of plasmid-mediated IMP-1 metallo-beta-lactamase and quinolone resistance determinants in an ertapenem-resistant Enterobacter cloacae isolate. J Zhejiang Univ Sci B 10, 348-354.
6. CLSI (2006). Performance Standards for Antimicrobial Susceptibility Testing; Supplement M100-S16. Wayne, PA: Clinical and Laboratory Standards Institute.
7. Conejo, M. C., Hernández, J. R. & Pascual, A. (2008). Effect of porin loss on the activity of tigecycline against Klebsiella pneumoniae producing extended-spectrum beta-lactamases or plasmid-mediated AmpC-type beta-lactamases. Diagn Microbiol Infect Dis 61, 343-345.
8. Giske, C. G., Monnet, D. L., Cars, O., Carmeli, Y. on behalf of ReAct- Action on Antibiotic Resistance (2008). Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother 52, 813-821.
9. Hawkey, P. & Finch, R. (2007). Tigecycline: in-vitro performance as a predictor of clinical efficacy. Clin Microbiol Infect 13, 354-362.
10. Hernández-Allés, S., Albertí, S., Alvarez, D., Doménech-Sánchez, A., Martínez-Martínez, L., Gil, J., Tomás, J. M. & Benedí, V. J. (1999). Porin expression in clinical isolates of Klebsiella pneumoniae. Microbiology 145, 673-679.
11. Hornsey, M., Ellington, M. J., Doumith, M., Thomas, C. P., Gordon, N. C., Wareham, D. W., Quinn, J., Lolans, K., Livermore, D. M. & Woodford, N. (2010). AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii. J Antimicrob Chemother 65, 1589-1593.
12. Kelesidis, T., Karageorgopoulos, D. E., Kelesidis, I. & Falagas, M. E. (2008). Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. J Antimicrob Chemother 62, 895-904.
13. Li, J., Nation, R. L., Milne, R. W., Turnidge, J. D. & Coulthard, K. (2005). Evaluation of colistin as an agent against multi-resistant Gramnegative bacteria. Int J Antimicrob Agents 25, 11-25.
14. Morosini, M. I., García-Castillo, M., Coque, T. M., Valverde, A., Novais, A., Loza, E., Baquero, F. & Cantón, R. (2006). Antibiotic coresistance in extended-spectrum-β-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline. Antimicrob Agents Chemother 50, 2695-2699.
15. Pérez-Pérez, F. J. & Hanson, N. D. (2002). Detection of plasmidmediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40, 2153-2162.
16. Pliatsika, V., Afkou, Z., Protonotariou, E. & Sofianou, D. (2007). In vitro activity of tigecycline against metallo-β-lactamase-producing Enterobacteriaceae. J Antimicrob Chemother 60, 1406-1407.
17. Queenan, A. M. & Bush, K. (2007). Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 20, 440-458.
18. Shen, P., Wei, Z., Jiang, Y., Du, X., Ji, S., Yu, Y. & Li, L. (2009). Novel genetic environment of the carbapenem-hydrolyzing β-lactamase KPC-2 among Enterobacteriaceae in China. Antimicrob Agents Chemother 53, 4333-4338.
19. Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H. & Swaminathan, B. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33, 2233-2239.
20. Townsend, M. L., Pound, M. W. & Drew, R. H. (2006). Tigecycline: a new glycylcycline antimicrobial. Int J Clin Pract 60, 1662-1672.
21. Versalovic, J., Koeuth, T. & Lupski, J. R. (1991). Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res 19, 6823-6831.
22. Wang, X. D., Cai, J. C., Zhou, H. W., Zhang, R. & Chen, G. X. (2009). Reduced susceptibility to carbapenems in Klebsiella pneumonia clinical isolates associated with plasmid-mediated β-lactamase production and OmpK36 porin deficiency. J Med Microbiol 58, 1196-1202.
23. Wei, Z. Q., Du, X. X., Yu, Y. S., Shen, P., Chen, Y. G. & Li, L. J. (2007). Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother 51, 763-765.
24. Wu, Q., Liu, Q., Han, L., Sun, J. & Ni, Y. (2010). Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 and ArmA 16S rRNA methylase conferring high-level aminoglycoside resistance in carbapenem- resistant Enterobacter cloacae in China. Diagn Microbiol Infect Dis 66, 326-328.
25. Yang, Q., Wang, H., Sun, H., Chen, H., Xu, Y. & Chen, M. (2010). Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospitalbased surveillance studies in China. Antimicrob Agents Chemother 54, 573-577.
26. NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumonia sequence type 14 from India. Antimicrob Agents Chemother 53, 5046-5054.
27. Yu, Y., Ji, S., Chen, Y., Zhou, W., Wei, Z., Li, L. & Ma, Y. (2007). Resistance of strains producing extended-spectrum beta-lactamases and genotype distribution in China. J Infect 54, 53-57.
28. Zhang, R., Zhou, H. W., Cai, J. C. & Chen, G. X. (2007). Plasmidmediated carbapenem-hydrolysing beta-lactamase KPC-2 in carbapenem- resistant Serratia marcescens isolates from Hangzhou, China. J Antimicrob Chemother 59, 574-576.
29. Zhang, R., Yang, L., Cai, J. C., Zhou, H. W. & Chen, G. X. (2008). Highlevel carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression. J Med Microbiol 57, 332-337.